Thoracic Oncology

Yes, on 8/19/25 we were given the following information from the individual whose contact information I am copying below. I apologize that it is likely not the response you wanted to hear (it certainly is not what we were hoping to hear):

At the moment, the drug will not be available for another 3 months as things are still being set up. I don’t have any new details to share just yet, but I will keep you posted on any updates as they become available. I really appreciate your patience and understanding.

With best regards,

Sadashiva Swamy

Sr. Global Study Leader

T: + 86 21 6109 5842

Our specialty pharmacy had initially been in contact with someone who said it would be available Q4 of this year but have since found out it likely won't be until 2026 sometime

Hi all - was curious if anyone's heard any recent updates regarding sunvozertinib access or have been successful in getting it at their institution?

Best,

-kevin

Hi Kevin,

I saw your message yesterday and I emailed the contact I have at Dizal.

This was the exact response I received this morning (see below). Frustrating, I know!

Dear Stefanie,

We appreciate your follow-up. Right now, we are actively working to establish the necessary infrastructure and processes to make the drug available through appropriate channels. While we do not yet have specific timelines or details to share, this remains a high priority for our team, and we are committed to keeping you informed as progress is made. We sincerely appreciate your patience and understanding as we navigate this transition.

With best regards,

Sadashiva Swamy

Sr. Global Study Leader

T: + 86 21 6109 5842

Hi! Just curious if anyone has heard another update regarding sunvozertinib access now that we're into 2026?

Thanks,
Cami

Replying to Cami--I last asked on 12/9/25 and got the response below. I am sure that I am REALLY annoying to them because I send this guy an email about once every 2 months. I can email him again if it would be helpful:

Dear Stefanie,

At this stage, the details are still under discussion, so I am not yet able to provide definitive information. We will let you know as soon as we have confirmed timelines.

With best regards,

Sadashiva Swamy

Sr. Global Study Leader

T: + 86 21 6109 5842

I also had emailed that individual last week and got the same response on 1/29:

Dear Jasmine,

Thank you for your follow-up. We are actively working to establish the necessary infrastructure and processes to make the drug available through appropriate channels. While we do not yet have specific timelines or details to share, this remains a top priority for our team. We sincerely appreciate your patience and understanding as we navigate this transition.

With best regards,

Sadashiva Swamy

Sr. Global Study Leader